Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response-Reference-Cited by-同舟云学术

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response

Published:2015-03-20 Issue:1 Volume:17 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Jézéquel Pascal,Loussouarn Delphine,Guérin-Charbonnel Catherine,Campion Loïc,Vanier Antoine,Gouraud Wilfried,Lasla Hamza,Guette Catherine,Valo Isabelle,Verrièle Véronique,Campone Mario

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-015-0550-y.pdf

Reference55 articles.

1. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–48.

2. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.

3. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–74.

4. Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol. 2011;5:5–23.

5. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 2007;8:R76.

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving therapeutics and ensuing cardiotoxicities in triple-negative breast cancer;Cancer Treatment Reviews;2024-11

2. Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer;Scientific Reports;2024-09-13

3. ReCIDE: robust estimation of cell type proportions by integrating single-reference-based deconvolutions;Briefings in Bioinformatics;2024-07-25

4. Assessment and process optimization of high throughput biofabrication of immunocompetent breast cancer model for drug screening applications;Biofabrication;2024-06-27

5. FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer;EMBO Molecular Medicine;2024-06-26